Suven Life Sciences Limited

Suven Life Sciences Limited has informed the Exchange regarding a press release dated Jun 04, 2026, titled “Suven Life Sciences Reports Positive DSMB Safety Review and Interim Analysis from Ongoing Global Phase 3 Study of Masupirdine in Alzheimer’s Disease Agitation at 50% study completers Study to Continue Unchanged”. |SUBJECT: Press Release Source link

Read More

Coforge Limited

COFORGE LIMITED has informed the Exchange about Board Meeting to be held on 27-Jul-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended June 2026 . |SUBJECT: Board Meeting Intimation Source link

Read More